BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Memirie ST, Desalegn H, Naizgi M, Nigus M, Taddesse L, Tadesse Y, Tessema F, Zelalem M, Girma T. Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation. Cost Eff Resour Alloc 2020;18:23. [PMID: 32704237 DOI: 10.1186/s12962-020-00219-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Akbar SMF, Al Mahtab M, Begum F, Hossain SAS, Sarker S, Shrestha A, Khan MSI, Yoshida O, Hiasa Y. Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia. Vaccines (Basel) 2021;9:374. [PMID: 33921259 DOI: 10.3390/vaccines9040374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana NLR, Tabala M, Fathy M, Kawende B, Muwonga J, Misingi P, Mbendi C, Luhata C, Jhaveri R, Cloherty G, Kaba D, Yotebieng M, Parr JB. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study. Lancet Glob Health 2021;9:e1600-9. [PMID: 34416175 DOI: 10.1016/S2214-109X(21)00304-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]